TOPICS: Heparin, anticoagulant, antithrombin III, factor IIa, thrombin, factor Xa, ptt, low molecular weight heparin, lmwh, enoxaparin, dalteparin, fibrin meshwork, fondaparinux, synthetic heparin, renally excreted, bioavailability, half life, pulmonary embolism, acute coronary syndromes, deep venous thrombosis, myocardial infarction, pregnancy, bleeding, thrombocytopenia, hit, platelet count, osteoporosis, protamine sulfate, severe uncontrolled hypertension, uncontrolled active bleed, kidney disease
